Published on 3/27/2018 in the Prospect News Structured Products Daily.
New Issue: Barclays prices $9.8 million phoenix autocallables on three ETFs
By Wendy Van Sickle
Columbus, Ohio, March 27 – Barclays Bank plc priced $9.8 million of phoenix autocallable notes due March 26, 2020 linked to the least performing of the Technology Select Sector SPDR fund, the SPDR S&P Bank ETF and the SPDR S&P Biotech exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will pay a contingent quarterly coupon at an annual rate of 15% if each ETF closes at or above its 74.05% coupon barrier on the observation date for that period.
The notes will be called at par plus the contingent coupon if each ETF closes at or above its initial price on any observation date.
The payout at maturity will be par unless any ETF finishes below its 74.05% barrier price, in which case investors will be fully exposed to any losses of the worst performing ETF.
Barclays is the agent.
Issuer: | Barclays Bank plc
|
Issue: | Phoenix autocallable notes
|
Underlying funds: | Technology Select Sector SPDR fund, SPDR S&P Bank ETF, SPDR S&P Biotech exchange-traded fund
|
Amount: | $9,799,000
|
Maturity: | March 26, 2020
|
Coupon: | 15% annualized, payable quarterly if each ETF closes at or above coupon barrier on observation date for that period
|
Price: | Par
|
Payout at maturity: | Par plus contingent coupon unless any ETF finishes below barrier, in which case full exposure to losses of least performing ETF
|
Call: | At par plus contingent coupon if each ETF closes at or above initial price on any observation date
|
Initial prices: | $88.60 for biotech, $46.75 for bank, $64.28 for technology
|
Coupon barriers: | $65.61 for biotech, $34.62 for bank, $47.60 for technology, 74.05% of initial price
|
Barriers: | $65.61 for biotech, $34.62 for bank, $47.60 for technology, 74.05% of initial price
|
Pricing date: | March 23
|
Settlement date: | March 28
|
Agent: | Barclays
|
Fees: | 1.75%
|
Cusip: | 06746X2V4
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.